Ryan Zimmerman
Stock Analyst at BTIG
(3.46)
# 720
Out of 5,180 analysts
249
Total ratings
42.4%
Success rate
5.22%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XTNT Xtant Medical Holdings | Maintains: Buy | $1.5 → $1 | $0.50 | +100.00% | 4 | Mar 31, 2026 | |
| HUMA Humacyte | Maintains: Buy | $6 → $3 | $0.65 | +364.32% | 8 | Mar 27, 2026 | |
| ORGO Organogenesis Holdings | Reiterates: Buy | $8 | $2.22 | +260.36% | 12 | Mar 26, 2026 | |
| MDAI Spectral AI | Reiterates: Buy | $3 | $1.45 | +106.90% | 4 | Mar 25, 2026 | |
| ALC Alcon | Reiterates: Buy | $92 | $75.13 | +22.45% | 15 | Mar 23, 2026 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | n/a | $91.07 | - | 12 | Mar 23, 2026 | |
| GEHC GE HealthCare Technologies | Reiterates: Buy | $91 | $70.45 | +29.17% | 7 | Mar 19, 2026 | |
| LNSR LENSAR | Upgrades: Buy | $10 | $5.91 | +69.20% | 2 | Mar 18, 2026 | |
| SI Shoulder Innovations | Maintains: Buy | $23 → $24 | $14.49 | +65.63% | 2 | Mar 11, 2026 | |
| KIDS OrthoPediatrics | Maintains: Buy | $23 → $24 | $16.08 | +49.25% | 11 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $63.64 | +57.13% | 3 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $43 | $22.97 | +87.20% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $131 | $111.76 | +17.22% | 17 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $38 | $24.69 | +53.91% | 6 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $412 | $329.96 | +24.86% | 19 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $616 | $456.78 | +34.86% | 23 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $349 | $330.06 | +5.74% | 21 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $9.74 | +146.41% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $3.68 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.42 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $75.64 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $117.36 | +66.16% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $34.15 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $25.26 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $102.93 | +43.79% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.62 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $87.94 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $9.51 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $20.12 | +163.42% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.56 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $178.49 | +12.05% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $205.48 | +70.33% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $86.16 | +48.56% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $15.72 | +167.18% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $6.59 | +696.66% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $34.04 | - | 3 | Apr 2, 2020 |
Xtant Medical Holdings
Mar 31, 2026
Maintains: Buy
Price Target: $1.5 → $1
Current: $0.50
Upside: +100.00%
Humacyte
Mar 27, 2026
Maintains: Buy
Price Target: $6 → $3
Current: $0.65
Upside: +364.32%
Organogenesis Holdings
Mar 26, 2026
Reiterates: Buy
Price Target: $8
Current: $2.22
Upside: +260.36%
Spectral AI
Mar 25, 2026
Reiterates: Buy
Price Target: $3
Current: $1.45
Upside: +106.90%
Alcon
Mar 23, 2026
Reiterates: Buy
Price Target: $92
Current: $75.13
Upside: +22.45%
Zimmer Biomet Holdings
Mar 23, 2026
Downgrades: Neutral
Price Target: n/a
Current: $91.07
Upside: -
GE HealthCare Technologies
Mar 19, 2026
Reiterates: Buy
Price Target: $91
Current: $70.45
Upside: +29.17%
LENSAR
Mar 18, 2026
Upgrades: Buy
Price Target: $10
Current: $5.91
Upside: +69.20%
Shoulder Innovations
Mar 11, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $14.49
Upside: +65.63%
OrthoPediatrics
Feb 27, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $16.08
Upside: +49.25%
Feb 27, 2026
Reiterates: Buy
Price Target: $100
Current: $63.64
Upside: +57.13%
Feb 26, 2026
Maintains: Buy
Price Target: $41 → $43
Current: $22.97
Upside: +87.20%
Feb 18, 2026
Reiterates: Buy
Price Target: $131
Current: $111.76
Upside: +17.22%
Feb 18, 2026
Maintains: Buy
Price Target: $36 → $38
Current: $24.69
Upside: +53.91%
Jan 30, 2026
Maintains: Buy
Price Target: $410 → $412
Current: $329.96
Upside: +24.86%
Jan 23, 2026
Reiterates: Buy
Price Target: $616
Current: $456.78
Upside: +34.86%
Jan 16, 2026
Downgrades: Neutral
Price Target: $349
Current: $330.06
Upside: +5.74%
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $9.74
Upside: +146.41%
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $3.68
Upside: -
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.42
Upside: -
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $75.64
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $117.36
Upside: +66.16%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $34.15
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $25.26
Upside: -
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $102.93
Upside: +43.79%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $6.62
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $87.94
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $9.51
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $20.12
Upside: +163.42%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $11.56
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $178.49
Upside: +12.05%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $205.48
Upside: +70.33%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $86.16
Upside: +48.56%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $15.72
Upside: +167.18%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $6.59
Upside: +696.66%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $34.04
Upside: -